Table 1 Demographics and underlying conditions of 31 patients with invasive fungal tracheobronchitis
Variable | No. of patients (%) |
|---|---|
Age, years (mean ± SD) | 64.7 ± 13.7 |
Gender, male | 24 (77.4) |
Current/ex-smoker | 15 (48.4) |
Underlying disease | 30 (96.8) |
DM | 18 (58.1) |
Chronic lung disease | 12 (38.7) |
COPD/asthma | 8 (25.8) |
Old TB | 2 (6.5) |
Bronchiectasis | 2 (6.5) |
Solid organ cancer | 4 (12.9) |
Hematologic disease | 4 (12.9) |
Liver cirrhosis | 3 (9.7) |
Systemic steroids before diagnosis | 17 (54.8) |
Duration of steroids before ICU admission, day, median (IQR) | 49 (14–90) |
Daily dosage of steroids, mg, median (IQR) | 50 (29–71) |
Inhaled corticosteroids before diagnosis | 3 (9.7) |
H1N1 infection before diagnosis | 3 (9.7) |